HCG is scaling up well, led by robust demand and its dominant cancer care positioning. At the current valuation, an investment in HCG has potential to more than double over the next couple of years.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.